Inozyme Pharma, Inc.

Pharmaceutical Preparations·BOSTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/10/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
10-Q	Q2 2024	6/30/24	8/6/24	→
10-Q	Q1 2024	3/31/24	5/7/24	→
10-K	FY 2023	12/31/23	3/12/24	→
↓

Earnings Releases (8-K)

21 shown

Filed	Period
3/10/25	Q1 FY2025	→
1/10/25	Q4 FY2025	→
11/5/24	Q4 FY2024	→
8/6/24	Q3 FY2024	→
5/7/24	Q2 FY2024	→
3/12/24	Q1 FY2024	→
↓

News (8-K)

30 shown

Filed	Type	Description
7/1/25	Delisting	Termination of a Material Definitive Agreement	→
6/23/25	Other	Other Events	→
6/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/16/25	Agreement	Entry into a Material Definitive Agreement	→
5/14/25	Acquisition	Completion of Acquisition or Disposition of Assets	→
10/24/24	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

28 shown

Filed	Form	Description
7/1/25	S-8 POS	S-8 POS	→
7/1/25	S-8 POS	S-8 POS	→
7/1/25	S-8 POS	S-8 POS	→
7/1/25	S-8 POS	S-8 POS	→
7/1/25	S-8 POS	S-8 POS	→
7/1/25	S-8 POS	S-8 POS	→
↓

Filing History(378 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13D/A

Aug 27, 2025

0000950170-25-111753

—

18.3 KB

SCHEDULE 13G/A

Aug 14, 2025

0000935836-25-000513

—

22.2 KB

SCHEDULE 13G/A

Aug 13, 2025

0001172661-25-003156

—

14.3 KB

SCHEDULE 13G/A

Aug 12, 2025

0000902664-25-003501

—

11.6 KB

SCHEDULE 13G/A

Jul 17, 2025

0002052113-25-003071

—

10.5 KB

15-12G

Jul 11, 2025

0001193125-25-15780915-12G

—

10.6 KB

Jul 3, 2025

0000950170-25-0941034

Jul 1, 2025

15.3 KB

Jul 3, 2025

0000950170-25-0940984

Jul 1, 2025

11.3 KB

Jul 3, 2025

0000950170-25-0940964

Jul 1, 2025

10.6 KB

Jul 3, 2025

0000950170-25-0940934

Jul 1, 2025

6.8 KB

Jul 3, 2025

0000950170-25-0940914

Jul 1, 2025

13.3 KB

Jul 3, 2025

0000950170-25-0940894

Jul 1, 2025

9.3 KB

EFFECT

Jul 1, 2025

9999999995-25-002117

—

1.8 KB

EFFECT

Jul 1, 2025

9999999995-25-002110

—

1.8 KB

25-NSE

Jul 1, 2025

0001354457-25-000600

—

3.0 KB

S-8 POS

Jul 1, 2025

0001193125-25-153657S-8 POS

—

26.3 KB

S-8 POS

Jul 1, 2025

0001193125-25-153654S-8 POS

—

26.3 KB

S-8 POS

Jul 1, 2025

0001193125-25-153651S-8 POS

—

26.3 KB

S-8 POS

Jul 1, 2025

0001193125-25-153636S-8 POS

—

26.3 KB

S-8 POS

Jul 1, 2025

0001193125-25-153635S-8 POS

—

26.3 KB

S-8 POS

Jul 1, 2025

0001193125-25-153632S-8 POS

—

26.3 KB

POS AM

Jul 1, 2025

0001193125-25-153591POS AM

—

22.4 KB

POS AM

Jul 1, 2025

0001193125-25-153585POS AM

—

22.4 KB

8-K

Jul 1, 2025

0001193125-25-1535828-K

Jul 1, 2025

314.7 KB

SC 14D9/A

Jul 1, 2025

0001193125-25-153577SC 14D9/A

—

16.8 KB

25 filings shown

Filed	Form	Description
6/23/25	DEFA14A	DEFA14A	→
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
↓

Inozyme Pharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(378 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
7/3/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
7/3/25	4	4	→
↓

Filed	Form	Description
8/27/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/13/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/12/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/17/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/11/25	15-12G	15-12G	→
↓